Aberrant Eph expression (increases or decreases) is observed in many human cancers in particular colorectal, prostate, breast cancers and interestingly in melanomas and gliomas where it correlates with patient survival, tumor prognosis, grade, metastasis, migration and invasion3, 7, 8, 9, 10, 11, 12. This evidence concerns the gene EPHA1 and cancer.